August 31, 2020
GoodRx, an online pharmacy platform for low-cost prescriptions and price comparisons, filed SEC documents seeking to go public on Nasdaq Friday.
Founded in 2011, GoodRx made its name with a platform and mobile app that lets self-paying customers compare medication prices and discounts. Users can bring a printed or digital coupon to major pharmacies when ordering their prescriptions. The platform...
August 4, 2020
GoodRx, an online pharmacy platform for low-cost prescriptions and price comparisons, has submitted the SEC forms necessary for an IPO, Reuters reports.
The timing of the startup's listing is still in the air, however, with 2020 and early 2021 both on the table depending on developments in the market, according to the anonymous source. GoodRx is still in the process of hiring advisors for the...
August 3, 2020
Israeli "digital X-ray" startup Nanox filed a Form F-1 with the SEC on Friday that outlines plans to raise $125 million in an IPO.
The company has applied to list its shares on the Nasdaq exchange as "NNOX," and according to a representative has entered its quiet period prior to the IPO.
Nanox, which has raised $110 million from investors since November 2019, is building a two-part offering...
June 8, 2020
Telemedicine giant AmWell is looking to go public, following a surge in use amid the coronavirus, CNBC first reported. The company declined to comment on news of the IPO when MobiHealthNews reached out.
CNBC is reporting that the Boston-based company hired Goldman Sachs and Morgan Stanley to broker the deal, which is expected to take place in September.
This news comes only weeks after the...
March 2, 2020
Health-benefits navigation platform Accolade announced on Friday the filing of its S-1 with the US Securities and Exchange Commission, making it the next digital-health company in line to join the public markets.
Accolade has set a $100 million maximum aggregate offering price to calculate its registration fee, but has not yet locked down the price and volume of its share offering.
January 31, 2020
Tech-enabled primary care business 1Life Healthcare — better known by its brand name, One Medical — hit the public market Friday after announcing the sale of 17.5 million shares at $14 each. This pricing alongside the roughly 122 million outstanding shares disclosed in the company’s S-1 would put One Medical’s valuation at just over $1.7 billion.
And although it’s only been on the market for a...
January 6, 2020
After months of rumors, the tech-enabled primary care provider One Medical has filed for an IPO. The company has tapped JP Morgan and Morgan Stanley to act as the lead bookrunning managers for the proposed offering.
While the stock price is not yet set, the company's SEC filing revealed that it is looking to raise around $100 million in the offering. The company plans to list itself on the...
September 26, 2019
Connected fitness company Peloton priced its IPO last night, raising $1.16 billion with shares priced at $29 a piece. That price didn't hold for too long, with the company closing its day out at $25.76.
According to Bloomberg, this makes Peloton the third-worst US trading debut in 10 years for companies that have raised at least $1 billion prior to their IPO.
The dip may partly be tied to Peloton...
Glen Tullman (second from right) at work with the Livongo team. Photo courtesy Livongo.
September 11, 2019
Livongo isn’t the first company in the digital health space to IPO — at least, depending on how you define “digital health” it isn’t. But even if your definition is broad, Livongo stands out as one of the first companies to go public that’s really focusing on delivering healthcare, not just wellness, using consumer digital technologies.
“People expect us to represent this whole new industry that...
August 29, 2019
Connected fitness company Peloton released its IPO prospectus Tuesday, revealing grim financials, even by today's startup IPO standards: the company lost nearly $200 million in FY 2019, four times what it lost the previous year. The document also contains plenty of reminders of the company's ongoing legal struggles relating to its music licensing and alleged patent infringement.
Yet, according to...